Jove
Visualize
Contact Us

Related Experiment Videos

[Mycoplasma infections].

B Roca1

  • 1Servicio de Medina Interna e Infecciones, Hospital General de Castellón, Universidad de Valencia. brocav@meditex.es

Revista Clinica Espanola
|June 6, 2006
PubMed
Summary
This summary is machine-generated.

Mycoplasmas, bacteria lacking cell walls, cause respiratory and urogenital infections. Future molecular diagnostics and current antibiotics like tetracyclines offer better management of these common human pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine.

Journal of postgraduate medicine·2021
Same author

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

HIV medicine·2016
Same author

Punctate inner choroidopathy complicated with exudative neurosensory detachment: A favourable response to treatment with systemic corticosteroids and intravitreal ranibizumab.

Archivos de la Sociedad Espanola de Oftalmologia·2016
Same author

Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.

HIV medicine·2016
Same author

Acute prostatitis probably due to Listeria monocytogenes in an HIV-infected patient.

International journal of STD & AIDS·2014
Same author

Pandemic H1N1 influenza-associated myocarditis in a patient with Castleman's disease.

Scottish medical journal·2013
Same journal

Vaccination status of patients undergoing HIV treatment in a hospital in Madrid.

Revista clinica espanola·2026
Same journal

Sulfonylureas and fracture risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Revista clinica espanola·2026
Same journal

Risk factors for the development of in-hospital complications in pluripathological patients.

Revista clinica espanola·2026
Same journal

Features, treatment and 1-year prognosis of patients with heart failure and chronic kidney disease stages 4 or 5.

Revista clinica espanola·2026
Same journal

Notification of suspected adverse drug reactions by nurses to a hospital pharmacovigilance program. Retrospective descriptive study.

Revista clinica espanola·2026
Same journal

Venous thromboembolic disease associated with hormonal contraceptives. Venous Thromboembolism Group of the Spanish Society of Internal Medicine and the Catalan Society of Contraception.

Revista clinica espanola·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Microbiology
  • Infectious Diseases

Context:

  • Mycoplasmas are wall-less prokaryotes colonizing mucosal surfaces.
  • Pathogenic species Mycoplasma pneumoniae, M. genitalium, M. hominis, and Ureaplasma urealyticum cause significant human infections.

Purpose:

  • To review the characteristics, diagnosis, and treatment of Mycoplasma and Ureaplasma infections.
  • To highlight the limitations of current diagnostic methods and the potential of emerging molecular techniques.

Summary:

  • Mycoplasma pneumoniae causes respiratory illnesses, while M. genitalium, M. hominis, and Ureaplasma urealyticum are linked to genitourinary infections.
  • Current diagnosis relies heavily on serology, which is time-consuming.
  • Tetracyclines and fluoroquinolones demonstrate potent antimicrobial activity against these organisms.

Related Experiment Videos

Impact:

  • Improved diagnostic strategies, including molecular methods, are anticipated to enhance patient outcomes.
  • Understanding Mycoplasma and Ureaplasma infections is crucial for effective clinical management and public health.
  • Antimicrobial susceptibility data guides the selection of effective treatments, such as tetracyclines and fluoroquinolones.